“Spirometer Market Over USD 700.1 million in 2020”, says Visiongain report

31 October 2019
Pharma

Visiongain’s new report the Spirometer Market Report 2020-2030: Forecasts by Product (Hand Held, Table Top, and Desktop), by Technology (Flow Measurement, Peak Flow Measurement, Volume Measurement), by Application (COPD, Asthma, Pulmonary Fibrosis, Cystic Fibrosis, and Others) by End Use (Home Use and Hospitals & Clinics) plus analysis of leading companies indicates that the global spirometer market will cross 1.5 billion revenue by 2030.

Global Spirometer Market is expected to grow on account of its rising demand from multispecialty hospitals pertaining to rising prevalence of lung disorders amongst teenagers and children. With increasing pollution across the globe, problems such as chest congestion, smoke allergies result in hospital admission where doctors often use spirometer for evaluating patient’s lung capacity.

The exponential increase in the incidence of COPD coupled with rising air pollution levels in developing economies like China and India are likely to drive the demand for spirometers within these countries. Technological improvements with respect to monitoring coupled with extensive pipeline research on anti-asthmatic drugs are expected to propel the market growth for spirometers in coming years.

Manufacturers have started design improvement from traditional spirometers to advanced ones. Of which peak flow meters come with innovative features enabling ease for the patient for using the device. Key players are concentrating on offering easy to use spirometers in order to increase their presence and gain competitive advantage over other market players.

Presence of large pool of patients suffering from COPD and asthma coupled with large ratio of new born with child asthma reflect the growth in demand for spirometers in developed as well as developing economies. As per Department of Health in the U.S., in 2011, over 800,000 people were diagnosed with COPD and the rate of diagnosis has went up to 27% in last 10 years.

On the basis of product, introduction of compact spirometers by many leading manufacturers have been a remarkable milestone. These compact spirometers being easy to carry have gained utmost popularity especially for home use. However, desktop spirometers are likely to grow at a fastest growth rate compared to counterparts pertaining to integration of computer technology in it. This computer based spirometers display integrated data for clinical decisions. Such characteristics are likely to fuel the segment growth by 2030.

In terms of technology, peak flow spirometers are likely to show most lucrative growth by 2030 on account of modern design and compatibility with oximeter. Peak flow spirometers enables breathing pattern and ventilation monitoring making it first choice of medical practitioners.

Within the application segment, COPD is likely to hold maximum market share in on account of high prevalence of COPD in children and teenagers in top 5 populous countries. Additionally, high pollution levels in these countries often make people prone to lung disorders making lung diagnosis essential where spirometers act as a must have equipment.

In terms of region, Asia Pacific is likely to emerge as a most lucrative market for spirometer on account of rising geriatric population in Japan coupled with rapid industrialization in India causing air pollution.

Key Players:

  1. Welch Allyn
  2. Koninklijke Philips N.V.
  3. Geratherm Respiratory GmbH
  4. FUKUDA SANGYO CO., LTD.
  5. SCHILLER
  6. VYAIRE MEDICAL, INC.
  7. Smiths Medical
  8. Nihon Kohden Corporation
  9. NSPIRE HEALTH INC
  10. Vitalograph
  11. Labtech Ltd.
  12. SDI Diagnostics
  13. Ganshorn Medizin Electronic
  14. Cosmed srl
  15. Medset Medizintechnik GmbH

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Pharmaceutical Spray Drying Market Report 2021-2031

The rising prevalence of oncological disorders, lung infections, rising demand for customised drugs coupled with new orphan diseases discoveries, are few of the major reasons responsible for development of pharmaceutical spray drying market.

25 October 2021

Read

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

Read

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

Read

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever